Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, typically
characterized by anovulation, infertility, obesity, insulin resistance, and polycystic ovaries …

Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …

Polycystic ovary syndrome (PCOS) has multiple etiologies including ovarian and adrenal
hyperandrogenism, neuro-endocrine and hypothalamic-pituitary dysfunction, and disorders …

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 5–10% of
women of reproductive age. It generally manifests with oligo/anovulatory cycles, hirsutism …

Zinc is an essential microelement that plays many important functions in the body. It is
crucial for the regulation of cell growth, hormone release, immunological response and …

Abdominal adiposity, overweightness and obesity are frequently present in patients with
polycystic ovary syndrome (PCOS). A large body of evidence suggests that abdominal …

Purpose Polycystic ovary syndrome (PCOS) is the most common endocrine disorder that
affects women of reproductive age and is characterized by ovulatory dysfunction and/or …

OBJECTIVE: This review discusses androgen status in male and female obesity, according
to their specific phenotype, and the main mechanisms responsible. DESIGN: Published data …

The polycystic ovary syndrome (PCOS) is one of the most common causes of infertility due to
anovulation in women. The clinical features of PCOS are heterogeneous and may change …

Polycystic ovarian syndrome (PCOS) affects 4% to 12% of women of reproductive age. The
lack of well-defined diagnostic criteria makes identification of this common disease …